Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Egis patents compounds affecting the central and peripheral serotonergic system

Feb. 16, 1998

Nonpeptide GnRH antagonists disclosed by Merck & Co.

Feb. 16, 1998

CCKB/gastrin receptor antagonists with anxiolytic activity discovered at Rotta

Feb. 16, 1998

Orally active iron chelators in development at Novartis

Feb. 16, 1998

Hypocholesterolemic agents disclosed by Warner-Lambert

Feb. 16, 1998

M2 ligands reported for the treatment of dementia

Feb. 16, 1998

Biphenylsulfonamides with MMP-inhibitory effects developed at Warner-Lambert

Feb. 13, 1998

Roche discloses new 5-HT2B antagonists

Feb. 13, 1998

Chiroscience describes series with PDE/TNF-inhibitory properties

Feb. 13, 1998

Pharmacia & Upjohn reveals novel compounds and novel methods of treating NIDDM

Feb. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026